IMU Biosciences raised €13M in a Series A round in Jan 2024. The company is based in London, UK. Investors in the round: Molten Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
